# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022836
Filing Date
2022-08-15
Accepted
2022-08-15 15:51:16
Documents
112
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form20-f.htm iXBRL | 20-F | 2812271
2 |  | ex12-1.htm | EX-12.1 | 11481
3 |  | ex12-2.htm | EX-12.2 | 15063
4 |  | ex13-1.htm | EX-13.1 | 6803
5 |  | ex13-2.htm | EX-13.2 | 6671
6 |  | ex15-1.htm | EX-15.1 | 2631
7 |  | form20-f_001.jpg | GRAPHIC | 15339
8 |  | form20-f_002.jpg | GRAPHIC | 16674
9 |  | form20-f_003.jpg | GRAPHIC | 26144
10 |  | form20-f_004.jpg | GRAPHIC | 11448
11 |  | form20-f_005.jpg | GRAPHIC | 9630
12 |  | form20-f_006.jpg | GRAPHIC | 11018
13 |  | form20-f_007.jpg | GRAPHIC | 10683
14 |  | form20-f_008.jpg | GRAPHIC | 31485
15 |  | form20-f_009.jpg | GRAPHIC | 16982
| Complete submission text file | 0001493152-22-022836.txt |  | 9381526

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
16 | INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | okyo-20220331.xsd | EX-101.SCH | 83620
17 | INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | okyo-20220331_cal.xml | EX-101.CAL | 63426
18 | INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | okyo-20220331_def.xml | EX-101.DEF | 212759
19 | INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | okyo-20220331_lab.xml | EX-101.LAB | 456472
20 | INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | okyo-20220331_pre.xml | EX-101.PRE | 337732
106 | EXTRACTED XBRL INSTANCE DOCUMENT | form20-f_htm.xml | XML | 1517076

Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

EIN.: 000000000
Type: 20-F | Act: 34 | File No.: 001-41386 | Film No.: 221165413
SIC: 2836 Biological Products, (No Diagnostic Substances)